Breaking policy and perceptual barriers: BiosimilarsExperts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted Share XBreaking policy and perceptual barriers: Biosimilarshttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-policy-and-perceptual-barriers-biosimilars/
Teva’s Kim Innes on shaping the post-COVID future with the NHSLike all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her Share XTeva’s Kim Innes on shaping the post-COVID future with the NHShttps://pharmaphorum.com/views-analysis-sales-marketing/teva-kim-innes-on-shaping-the-post-covid-future-with-the-nhs/
Digital health and pharma – adapting to the post-coronavirus paradigmThe need for digital transformation and a response model for coronavirus were among the topics discussed in a Share XDigital health and pharma – adapting to the post-coronavirus paradigmhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/digital-health-and-pharma-adapting-to-the-post-coronavirus-paradigm/
Deep Dive: Market Access – Breaking BarriersIn this issue of Deep Dive we look at the changing landscape for pharma market access and start Share XDeep Dive: Market Access – Breaking Barriershttps://pharmaphorum.com/views-analysis-market-access/deep-dive-market-access/
6 ways to digitise your business at paceAs the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact? For decades, I have Share X6 ways to digitise your business at pacehttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/6-ways-to-digitise-your-business-at-pace/
Coronavirus pharma news roundup 15/5/20This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs Share XCoronavirus pharma news roundup 15/5/20https://pharmaphorum.com/r-d/views-analysis-r-d/coronavirus-pharma-news-roundup-15-5-20/
What COVID-19 means for generics companiesGenerics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change Share XWhat COVID-19 means for generics companieshttps://pharmaphorum.com/views-analysis-market-access/what-covid-19-means-for-generics-companies/
Coronavirus pharma news roundup – 1/5/2020This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales. Meanwhile, there were Share XCoronavirus pharma news roundup – 1/5/2020https://pharmaphorum.com/views-analysis-market-access/coronavirus-pharma-news-roundup-1-5-2020/
Daiichi Sankyo: pharma needs to become NHS ‘experts’If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership Share XDaiichi Sankyo: pharma needs to become NHS ‘experts’https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/
